MuddyWatersResearch Profile picture
Sep 14, 2020 5 tweets 2 min read Read on X
The $NKLA response is typical, but just so poor. Seriously, these crisis communication firms are stealing their clients’ money. First mistake is to play the ad hominem card - and hard by repeatedly saying “manipulation”. The big problem is company / Milton credibility... 1/
But the “rebuttals” are countering statements of fact (e.g., was not a $NKLA inverter) with safe harbor protected fluff (working hard on own inverters). Effectively, this release confirms the statements of FACT. It’s taking issue w/ @HindenburgRes OPINIONS from those facts... 2/
So repeatedly accusing @HindenburgRes of manipulation while confirming facts and arguing opinions is really discrediting of $NKLA. In my experience, investors see through this. So net-net company still has same credibility issue. Esp when NKLA is parsing language re “in motion”3/
Also going ad hominem just fires up the short seller more - every time. How should company have responded? Focus on milestones achieved since these events, announce concrete steps to improve transparency, show contrition, & then say @HindenburgRes has drawn wrong conclusions
By the way, MW / I have no position in NKLA & have never had one. For those of you strapping on your tinfoil hats thinking I’m trying to “hit” the stock to make money, go ahead and take them off. I’m an activist short seller expressing an opinion on these events - nothing more.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with MuddyWatersResearch

MuddyWatersResearch Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @muddywatersre

Mar 27
MW is short $APP. ~52% of e-com is retargeting. Incrementality only ~25%-35%. APP misappropriates user data from 3P platforms. It uses 3P data as black edge in auctions. Q1 E-com churn seems ~23%. APP is easily copied if not deplatformed muddywatersresearch.com/research/2025/…
Traffic for 37m users indicates ~52% of $APP e-com sales are retargeting. We estimate only ~25% to ~35% of sales are incremental. CEO claims e-com incrementality near 100%. We believe e-com business will never take off muddywatersresearch.com/research/2025/…
Supporting our view e-com business will never take off, we observed 776 $APP e-com clients in Q1 and saw ~23% churn. We suspect e-com clients are understanding that APP is in reality low ROAS muddywatersresearch.com/research/2025/…
Read 5 tweets
Jan 15
MW is short $FTAI bc we think FTAI misleads by shifting profits from Leasing to MRO, misrepresenting whole engine sales as 3 modules & channel stuffing at YE23 muddywatersresearch.com/research/2025/…Image
We estimate ~80% of FY24 modules are really whole engine sales counted as 3 modules each. We engaged a frmr snr exec to canvass $FTAI counterparties and assess the number of whole engines sold muddywatersresearch.com/research/2025/…
$FTAI EBITDA margins in excess of its peers bc hundreds of millions are incurred by Leasing—not MRO. ~70% of Aerospace Products COGS originated in Leasing before being transferred to Inventory
muddywatersresearch.com/research/2025/…Image
Read 7 tweets
May 16, 2023
MW is short $KDNY. We believe its lead drug, atrasentan, will never get FDA approval. Trial data have shown it's a) inefficacious and b) increases cardiac and mortality risks. AbbVie and KDNY have manipulated and misrepresented trial data to conceal muddywatersresearch.com/research/kdny/…
Atrasentan shows no sign of renal repair. Trial data show in our view $KDNY biomarker effects are hemodynamic effect (dilution), which lowered UACR. Post treatment, UACR converged with placebo. Systolic BP converged during treatment. Anemia stat sig higher muddywatersresearch.com/research/kdny/…
AbbVie and now $KDNY obscure the trial data by a) distorting time periods on charts, b) using a composite endpoint that combines negative and positive outcomes, and c) cherry picking data to give the impressions of efficacy and safety muddywatersresearch.com/research/kdny/…
Read 4 tweets
Jul 23, 2021
In June 2018, MW issued a report on $TAL “A Real Business With Fake Financials.” In June 2020, we reported on $GOTU concluding it’s a fake business w/ fake financials. What we see today isn’t directly a result of the fraud, but it is indirectly a result. 1/
The system that allows such frauds to persist and flourish is a highly corrupt system run by a highly corrupt autocratic government. A government that can’t be trusted - especially by foreigners who thought they were *beneficiaries* of this system. You were wrong. 2/
That is narcissism typical of western investors in China. It was clear once the CCP made the choice in 2012 to protect the frauds (e.g., through protecting auditors from SEC) that foreign capital was allowed to receive returns at the pleasure of the CCP, but that when push came…
Read 8 tweets
May 13, 2021
MW is short $LMND bc it has an egregious security vulnerability & utterly failed to secure customer PII. Customer PII has actually been indexed by Google and other search engines. Many customer accounts can be accessed without any authentication at all! muddywatersresearch.com/research/lmnd/…
$LMND should immediately take its site, API, and app offline to remediate. Breach seemingly existed since 7/2020, LMND must investigate scope of breach & inform all potentially affected customers. We think it’s likely a breach has occurred. muddywatersresearch.com/research/lmnd/…
$LMND security vuln is so obvious we *accidentally* discovered it during fundamental research & can be detected by industry standard app costing $400 / year. LMND could be liable under GDPR, NY fin service regs & CA Consumer Privacy Act muddywatersresearch.com/research/lmnd/…
Read 4 tweets
Mar 3, 2021
MW is short $XL bc it's middle of the fairway SPAC garbage. The real "green" tech is duping investors and customers through exaggerations, half truths, and mistruths. Claimed backlog is greatly exaggerated, purported customers haven't ordered in years. muddywatersresearch.com/research/xl/mw…
Former $XL salespeople tell of being forced to exaggerate pipelines, esp when the board was going to meet. "A minimum of four times a year [manager] would exaggerate my pipeline substantially to report to the board." muddywatersresearch.com/research/xl/mw…
Customer ROIs actually r negative. Former $XL employee describes a customer gain as "a blatant lie". 18 of 33 customers featured in investor deck reportedly r inactive. Reorder rate only ~10%. Tod Hynes y'day deflected @jimcramer customer question on this. muddywatersresearch.com/research/xl/mw…
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(